Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis

See also
Status	Clinical Trial	Phase
Completed	`NCT03190577` - Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology	N/A
Completed	`NCT03588468` - Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study	N/A
Completed	`NCT03591757` - Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)	Early Phase 1
Completed	`NCT05075798` - Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis Patients
Recruiting	`NCT05577819` - Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF	N/A
Terminated	`NCT04611204` - Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery
Completed	`NCT03352089` - Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis
Recruiting	`NCT05814380` - The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.
Completed	`NCT03923920` - Screening for Systemic Amyloidosis Via the Ligamentum Flavum
Completed	`NCT03886155` - Cardiac Amyloidosis Screening at Trigger Finger Release
Completed	`NCT02792790` - Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Completed	`NCT03860935` - Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy	Phase 3
Not yet recruiting	`NCT06465810` - Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Recruiting	`NCT04963985` - The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients	Phase 4
Recruiting	`NCT05409833` - Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population
Recruiting	`NCT05635045` - Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR	Phase 2
Completed	`NCT01171859` - Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis	Phase 2
Recruiting	`NCT03237494` - TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
Recruiting	`NCT04899180` - Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis	Early Phase 1
Recruiting	`NCT06345235` - New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

NCT number	NCT03862807
Study type	Interventional
Source	Alnylam Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	March 27, 2019
Completion date	October 20, 2020

Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms